JITC

System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma
Xu Wang, Tao Zhou, Xingyi Chen, Yu Wang, Yushi Ding, Haoyang Tu, Shengyang Gao, Haoyu Wang, Xinying Tang, Yong Yang

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004414; DOI: 10.1136/jitc-2021-004414
IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells
Nadine Landolina, Francesca Romana Mariotti, Tiziano Ingegnere, Claudia Alicata, Biancamaria Ricci, Andrea Pelosi, Irene Veneziani, Bruno Giuseppe Azzarone, Cecilia Garlanda, Alberto Mantovani, Lorenzo Moretta, Enrico Maggi

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003858; DOI: 10.1136/jitc-2021-003858
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer
Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Coureche Kaderbhai, Romain Boidot, Sandy Chevrier, Philippe Joubert, Bertrand Routy, Caroline Truntzer, Francois Ghiringhelli

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004241; DOI: 10.1136/jitc-2021-004241
Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
Douglas G McNeel, Jens C Eickhoff, Ellen Wargowski, Laura E Johnson, Christos E Kyriakopoulos, Hamid Emamekhoo, Joshua M Lang, Mary Jane Brennan, Glenn Liu

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004198; DOI: 10.1136/jitc-2021-004198
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
Daniel Alonso-Miguel, Guillermo Valdivia, Diego Guerrera, Maria Dolores Perez-Alenza, Stanislav Pantelyushin, Angela Alonso-Diez, Veronique Beiss, Steven Fiering, Nicole F Steinmetz, Maria Suarez-Redondo, Johannes vom Berg, Laura Peña, Hugo Arias-Pulido

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004044; DOI: 10.1136/jitc-2021-004044
Identification of natural product 3, 5-diiodotyrosine as APOBEC3B inhibitor to prevent somatic mutation accumulation and cancer progression
Chunxia Chen, Xinghua Sui, Haoming Ning, Yixuan Sun, Jiangfeng Du, Xiaotong Chen, Xiuman Zhou, Guanyu Chen, Wenhui Shen, Liwei Pang, Xiaowen Zhou, Ranran Shi, Wanqiong Li, Hongfei Wang, Wenshan Zhao, Wenjie Zhai, Yuanming Qi, Yahong Wu, Yanfeng Gao

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005503; DOI: 10.1136/jitc-2022-005503
Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor t-cell therapy
Yalda Amidi, Christine A Eckhardt, Syed A Quadri, Preeti Malik, Marcos Santana Firme, Daniel K Jones, Aayushee Jain, Husain H Danish, Daniel B Rubin, Caron A Jacobson, Sydney S Cash, Jong Woo Lee, Jorg Dietrich, M Brandon Westover

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005459; DOI: 10.1136/jitc-2022-005459
Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses
Antonella Vardeu, Charlotte Davis, Ian McDonald, Guilherme Stahlberg, Barsha Thapa, Kinga Piotrowska, Margaret A Marshall, Thomas Evans, Vicky Wheeler, Sarah Sebastian, Katie Anderson

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005398; DOI: 10.1136/jitc-2022-005398
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, Anja Gesierich, Matthias Goebeler, Detlef Klein, Christian Posch, Christoffer Gebhardt, Sebastian Haferkamp, Lisa Zimmer, Jürgen C Becker, Ulrike Leiter, Michael Weichenthal, Dirk Schadendorf, Selma Ugurel, Bastian Schilling

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005930; DOI: 10.1136/jitc-2022-005930
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy
Toni K Choueiri, Harriet Kluger, Saby George, Scott S Tykodi, Timothy M Kuzel, Ruth Perets, Suresh Nair, Giuseppe Procopio, Michael A Carducci, Vincent Castonguay, Edmund Folefac, Chung-Han Lee, Sebastien J. Hotte, Wilson H Miller,, Shruti Shally Saggi, Chung-Wei Lee, Heshani Desilva, Prabhu Bhagavatheeswaran, Robert J Motzer, Bernard Escudier

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005780; DOI: 10.1136/jitc-2022-005780

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages